Chudecka-Głaz, A.; Strojna, A.; Michalczyk, K.; Wieder-Huszla, S.; Safranow, K.; Skwirczyńska, E.; Jurczak, A.
Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy. Diagnostics 2023, 13, 452.
https://doi.org/10.3390/diagnostics13030452
AMA Style
Chudecka-Głaz A, Strojna A, Michalczyk K, Wieder-Huszla S, Safranow K, Skwirczyńska E, Jurczak A.
Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy. Diagnostics. 2023; 13(3):452.
https://doi.org/10.3390/diagnostics13030452
Chicago/Turabian Style
Chudecka-Głaz, Anita, Aleksandra Strojna, Kaja Michalczyk, Sylwia Wieder-Huszla, Krzysztof Safranow, Edyta Skwirczyńska, and Anna Jurczak.
2023. "Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy" Diagnostics 13, no. 3: 452.
https://doi.org/10.3390/diagnostics13030452
APA Style
Chudecka-Głaz, A., Strojna, A., Michalczyk, K., Wieder-Huszla, S., Safranow, K., Skwirczyńska, E., & Jurczak, A.
(2023). Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy. Diagnostics, 13(3), 452.
https://doi.org/10.3390/diagnostics13030452
